...
首页> 外文期刊>Biosensors & Bioelectronics: The International Journal for the Professional Involved with Research, Technology and Applications of Biosensers and Related Devices >Competitive electrochemical platform for ultrasensitive cytosensing of liver cancer cells by using nanotetrahedra structure with rolling circle amplification
【24h】

Competitive electrochemical platform for ultrasensitive cytosensing of liver cancer cells by using nanotetrahedra structure with rolling circle amplification

机译:用轧辊圆形扩增使用纳米型化地区结构的肝癌细胞超细胞瘤细胞溶解的竞争力电化学平台

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this work, a competitive and label-free electrochemical platform was performed for the ultrasensitive cytosensing of liver cancer cells based on DNA nanotetrahedron (NTH) structure and rolling circle amplification (RCA) directed DNAzyme strategy. The multifunctional nanoprobes were fabricated through a DNA primer probe, carboxyfluorescein (FAM) functionalized TLS11a aptamer and horseradish peroxidase (HRP) immobilized on the surfaces of the platinum nanoparticles (PtNPs). Then the NTH-based complementary DNA (cDNA) probe, complementary to the TLS11a aptamer, was attached on a disposable screen-printed gold electrode (SPGE) for increasing the reactivity and accessibility with the prepared nanoprobes. Due to the primer probe and the circular probe with G-quadruplex sequences for RCA, it can lead to the formation of numerous G-quadruplex/hemin DNAzyme, thus generating a remarkable electrochemical response. When the target cells were present, the nanoprobes were released from the SPGE due to the specific recognition of TLS11a aptamers for HepG2 cells, resulting in the electrochemical signal changes. The cytosensor was ultrasensitive for HepG2 tumor cell detection with a detection limit of 3 cell per mL. Furthermore, this strategy was also demonstrated to be applicable for cancer cell imaging. In summary, this electrochemical cytosensor holds great potential for circulating tumor cell detection in the early cancer diagnose.
机译:在这项工作中,对基于DNA纳米纳米二合一(NTH)结构和滚动圆扩增(RCA)指导的DNAzyme策略进行肝癌细胞的超细胞癌细胞进行超细胞癌细胞进行超细胞瘤细胞化学平台。通过DNA引物探针,羧基荧光素(FAM)官能化TLS11A适体和固定在铂纳米颗粒(PTNP)的表面上的旋过磷酸化酶(HRP)制造多官能纳米体。然后将Nth基互补DNA(cDNA)探针互补地与TLS11A适体互补,在一次性丝网印刷的金电极(SPEG)上附着,以增加与制备的纳米素物的反应性和可接受性。由于引物探针和RCA的G-Quadflex序列的圆形探针,它可以导致众多G-Quadreplex / Hemin dnazyme的形成,从而产生显着的电化学响应。当存在靶细胞时,由于HEPG2细胞的特异性识别TLS11a适体的特异性识别,纳米素被从末端释放出来。导致电化学信号发生变化。对于HEPG2肿瘤细胞检测,胞嘧胞传感器具有超声筛,每mL的3个细胞的检测限。此外,还证明了该策略适用于癌细胞成像。总之,这种电化学细胞传感器在早期癌症诊断中具有循环肿瘤细胞检测的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号